|
|
| Line 96: |
Line 96: |
| |<span class="blue-text">EXAMPLE:</span> | | |<span class="blue-text">EXAMPLE:</span> |
| Presence of monosomy 7 (or 7q deletion) is sufficient for a diagnosis of AML with MDS-related changes when there is ≥20% blasts and no prior therapy (add reference). Monosomy 7/7q deletion is associated with a poor prognosis in AML (add references). | | Presence of monosomy 7 (or 7q deletion) is sufficient for a diagnosis of AML with MDS-related changes when there is ≥20% blasts and no prior therapy (add reference). Monosomy 7/7q deletion is associated with a poor prognosis in AML (add references). |
| |-
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| 8
| |
| |<span class="blue-text">EXAMPLE:</span> Gain
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| chr8
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| Unknown
| |
| |<span class="blue-text">EXAMPLE:</span> D, P
| |
| |
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| Common recurrent secondary finding for t(8;21) (add references).
| |
| |-
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| 17
| |
| |<span class="blue-text">EXAMPLE:</span> Amp
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| 17q12; chr17:39,700,064-39,728,658 [hg38; 28.6 kb]
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| ''ERBB2''
| |
| |<span class="blue-text">EXAMPLE:</span> D, P, T
| |
| |
| |
| |<span class="blue-text">EXAMPLE:</span>
| |
| Amplification of ''ERBB2'' is associated with HER2 overexpression in HER2 positive breast cancer (add references). Add criteria for how amplification is defined.
| |
| |-
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |} | | |} |
|
| |
|
